However, like hereditary or acquired MPL [2,38] and CALR mutations [29], impaired MPL cell-surface expression is a feature of JAK2V617F-positive PV, ET and PMF [34–42] and presumably responsible for increased plasma THPO in these disorders [34,43,44]. The gene discussed is THPO; the disease is essential thrombocythemia.